aor 012 (Alomone Labs)
Structured Review
Aor 012, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+kappa+opioid+receptor/Anti-%CE%BA-Opioid+Receptor+(OPRK1)+(extracellular)+Antibody/pm40586679-60-17-18
Average 93 stars, based on 2 article reviews
Images
Related Articles
Immunohistochemical staining:Article Title: Synergic Effect of Botulinum Toxin Type A and Triamcinolone Alleviates Scar Pruritus by Modulating Epidermal Hyperinnervation: A Preliminary Report. Article Snippet: Background: Patients often experience scar-related pruritus, which adversely affects quality of life.. Triamcinolone acetonide (TAC) is widely used to treat pathologic scars, and botulinum toxin type-A (BTX-A) reportedly improves scarring and associated discomfort.. Objectives: The aim of this study was to investigate the clinical efficacy of combining TAC and BTX-A to reduce scar itch; potential mechanisms were investigated via an animal model. Methods: For the clinical study, each scar on a patient was divided into 2 equal parts, with one part receiving TAC/BTX-A and the other TAC alone. Staining:Article Title: Synergic Effect of Botulinum Toxin Type A and Triamcinolone Alleviates Scar Pruritus by Modulating Epidermal Hyperinnervation: A Preliminary Report. Article Snippet: Background: Patients often experience scar-related pruritus, which adversely affects quality of life.. Triamcinolone acetonide (TAC) is widely used to treat pathologic scars, and botulinum toxin type-A (BTX-A) reportedly improves scarring and associated discomfort.. Objectives: The aim of this study was to investigate the clinical efficacy of combining TAC and BTX-A to reduce scar itch; potential mechanisms were investigated via an animal model. Methods: For the clinical study, each scar on a patient was divided into 2 equal parts, with one part receiving TAC/BTX-A and the other TAC alone. |
